Impact of radioiodine therapy on recurrence and survival outcomes in intermediate-risk papillary thyroid carcinoma -A systematic review and meta-analysis.

Chandekar, Kunal Ramesh; Satapathy, Swayamjeet; Bal, Chandrasekhar

Chandekar, Kunal Ramesh; Satapathy, Swayamjeet; Bal, Chandrasekhar.

Affiliation

Chandekar KR; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Satapathy S; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Bal C; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.

Clin Endocrinol (Oxf) ; 100(2): 181-191, 2024 02.

Article in En | MEDLINE | ID: mdl-38050454

Subject(s)

Carcinoma, Papillary; Carcinoma; Thyroid Neoplasms; Humans; Thyroid Cancer, Papillary/radiotherapy; Thyroid Cancer, Papillary/surgery; Thyroid Neoplasms/pathology; Iodine Radioisotopes/therapeutic use; Carcinoma/surgery; Carcinoma, Papillary/radiotherapy; Carcinoma, Papillary/surgery; Prospective Studies; Neoplasm Recurrence, Local/surgery; Thyroidectomy; Retrospective Studies

Key words

intermediate-risk; papillary thyroid carcinoma (PTC); radioiodine (RAI); recurrence; survival outcomes

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thyroid Neoplasms / Carcinoma / Carcinoma, Papillary Type of study: Systematic_reviews Limits: Humans Language: En Journal: Clin Endocrinol (Oxf) Year: 2024 Type: Article Affiliation country: India

Fulltext

XML

PubMed Links

Search on Google